Judy Chamberlain
Manager Clinical Research and Operations at TG Therapeutics, Inc. - New York, NY, US
Judy Chamberlain's Colleagues at TG Therapeutics, Inc.
Xiaohong Shen
Senior Director, Pharmaceutical Development & Technology Transfer
Marisa Valentinetti
Regional Director, Oncology Nurse Educator Team-East
Judy Chamberlain's Contact Details
(212) 554-4484
Kansas City, Missouri
TG Therapeutics, Inc.
Judy Chamberlain's Company Details
TG Therapeutics is a biopharmaceutical company focused on the acquisition, development and commercialization of novel treatments for B-cell diseases. In addition to a research pipeline including several investigational medicines, TG has completed a Phase 3 program for ublituximab, an investigational glycoengineered monoclonal antibody that targets a unique epitope on CD20-expressing B-cells, to treat patients with relapsing forms of multiple sclerosis (RMS).